81 related articles for article (PubMed ID: 28615105)
1. [Over-expression of mdr1/P-gp is associated with methotrexate resistance in patients with rheumatoid arthritis].
Yao X; Sun Y; Ma W; Ning Q; Zeng P; Zhong Q; Hou L; Huang Y; Tang F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jun; 33(6):815-819. PubMed ID: 28615105
[TBL] [Abstract][Full Text] [Related]
2. [High Expression of Multidrug Resistance Gene-1 Can Aggravate Resistance to Methotrexate in Rheumatoid Arthritis Patients].
Wang J; Mao N; Xie X; Li S; Chen WJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):595-600. PubMed ID: 31699188
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of P-glycoprotein on fibroblast-like synoviocytes in refractory rheumatoid arthritis patients: a potential mechanism for multidrug resistance in rheumatoid arthritis treatment.
Liu YM; Chen JW; Chen LX; Xie X; Mao N
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323187
[TBL] [Abstract][Full Text] [Related]
4. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
Tsujimura S; Saito K; Nawata M; Nakayamada S; Tanaka Y
Ann Rheum Dis; 2008 Mar; 67(3):380-8. PubMed ID: 17660216
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate Combined with 4-Hydroperoxycyclophosphamide Downregulates Multidrug-Resistance P-Glycoprotein Expression Induced by Methotrexate in Rheumatoid Arthritis Fibroblast-Like Synoviocytes via the JAK2/STAT3 Pathway.
Qin K; Chen K; Zhao W; Zhao X; Luo J; Wang Q; Gao C; Li X; Wang C
J Immunol Res; 2018; 2018():3619320. PubMed ID: 29670920
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance protein-1 expression, function and polymorphisms in patients with rheumatoid arthritis not responding to methotrexate.
Prasad S; Tripathi D; Rai MK; Aggarwal S; Mittal B; Agarwal V
Int J Rheum Dis; 2014 Nov; 17(8):878-86. PubMed ID: 24734954
[TBL] [Abstract][Full Text] [Related]
7. High serum level of haptoglobin is associated with the response of 12 weeks methotrexate therapy in recent-onset rheumatoid arthritis patients.
Tan W; Wang F; Guo D; Ke Y; Shen Y; Lv C; Zhang M
Int J Rheum Dis; 2016 May; 19(5):482-9. PubMed ID: 24863583
[TBL] [Abstract][Full Text] [Related]
8. The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs.
Drozdzik M; Rudas T; Pawlik A; Kurzawski M; Czerny B; Gornik W; Herczynska M
Eur J Clin Pharmacol; 2006 Nov; 62(11):933-7. PubMed ID: 16932953
[TBL] [Abstract][Full Text] [Related]
9. Etanercept overcomes P-glycoprotein-induced drug resistance in lymphocytes of patients with intractable rheumatoid arthritis.
Tsujimura S; Saito K; Nakayamada S; Tanaka Y
Mod Rheumatol; 2010 Apr; 20(2):139-46. PubMed ID: 19915943
[TBL] [Abstract][Full Text] [Related]
10. MDR-1 and MRP-1 activity in peripheral blood leukocytes of rheumatoid arthritis patients.
Micsik T; Lőrincz A; Gál J; Schwab R; Peták I
Diagn Pathol; 2015 Dec; 10():216. PubMed ID: 26715450
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance 1 (MDR1) 3435C>T gene polymorphism influences the clinical phenotype and methotrexate-induced adverse events in South Indian Tamil rheumatoid arthritis.
Muralidharan N; Antony PT; Jain VK; Mariaselvam CM; Negi VS
Eur J Clin Pharmacol; 2015 Aug; 71(8):959-65. PubMed ID: 26071279
[TBL] [Abstract][Full Text] [Related]
13. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
[TBL] [Abstract][Full Text] [Related]
14. Improving P-gp expression in human mononuclear cells in vitro transfected by multidrug resistance-1 mRNA.
Xiang Y; Li L; Tian F; Yang XY
Chin Med Sci J; 2005 Mar; 20(1):48-50. PubMed ID: 15844313
[TBL] [Abstract][Full Text] [Related]
15. Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis.
Tang H; Wu YJ; Xiao F; Wang B; Asenso J; Wang Y; Sun W; Wang C; Wei W
Biomed Pharmacother; 2019 Nov; 119():109432. PubMed ID: 31521892
[TBL] [Abstract][Full Text] [Related]
16. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
17. Association of MDR1 C3435T and RFC1 G80A polymorphisms with methotrexate toxicity and response in Jordanian rheumatoid arthritis patients.
Samara SA; Irshaid YM; Mustafa KN
Int J Clin Pharmacol Ther; 2014 Sep; 52(9):746-55. PubMed ID: 25074866
[TBL] [Abstract][Full Text] [Related]
18. Reduced folate carrier 1 gene expression levels are correlated with methotrexate efficacy in Japanese patients with rheumatoid arthritis.
Tazoe Y; Hayashi H; Tsuboi S; Shioura T; Matsuyama T; Yamada H; Hirai K; Tsuji D; Inoue K; Sugiyama T; Itoh K
Drug Metab Pharmacokinet; 2015 Jun; 30(3):227-30. PubMed ID: 26003891
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of miR-16 enhances the sensitivity of fibroblast-like synovial cells to methotrexate by restraining MDR1/P-gp expression
Wang J; Mao N; Liu Y; Xie X; Tian J; Li F; Chen J
RSC Adv; 2019 Aug; 9(46):26619-26627. PubMed ID: 35528582
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis.
Dhir V; Singla M; Gupta N; Goyal P; Sagar V; Sharma A; Khanna S; Singh S
Clin Ther; 2014 Jul; 36(7):1005-15. PubMed ID: 24976447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
